Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA studyVincent Camus, Hervé Tilly, David Tonnelet et al.|Blood Advances|2021Cited by 51
OUTCOMES AFTER FIRST‐LINE IMMUNOCHEMOTHERAPY FOR PRIMARY MEDIASTINAL B CELL LYMPHOMA PATIENTS: A LYSA STUDYVincent Camus, Hervé Tilly, Cédric Rossi et al.|Hematological Oncology|2021Cited by 0